A&T Corporation develops, manufactures, and markets products in the fields of chemicals, analyzers, computers, and lab-logistics in Japan and internationally. It offers laboratory automation systems and managed pre-analysis modules; coagulation, electrolyte, and glucose analyzers; reagents for immunoassays; and CLINILAN, a laboratory resource planning system. The company was founded in 1978 and is headquartered in Yokohama, Japan.
Research context
A&T Corporation appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 7 months ago
A&T Corporation is currently in a long term uptrend where the price is trading 14.2% above its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
A&T Corporation's total revenue sank by 35.0% to $2B since the same quarter in the previous year.
Its net income has dropped by 138.8% to $-102M since the same quarter in the previous year.
Based on the above factors, A&T Corporation gets an overall score of 2/5.